{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:04:01Z","timestamp":1753877041242,"version":"3.41.2"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Bladder cancer (BC) is a common malignancy in Europe and North America. Among BCs, muscle-invasive BCs (MIBCs) are distinguished, as they require aggressive treatment due to their spreading potential and poor prognosis. Despite its clinical relevance, little information on MIBC in a general population setting is available. This study aims to report practice patterns and survival outcomes for MIBC patients in a general population setting. MIBCs among BC incidence in 2011 and 2012 recorded in a French population-based cancer registry (810\u2009000 inhabitants) were included in the study. Data were extracted from the medical files. Individual, tumour-related characteristics and initial management including diagnostic tools, multidisciplinary team meeting (MDT) assessment, and treatment delivered were described. Cystectomy, chemoradiation, radiotherapy, and chemotherapy were considered as specific treatments. Matching between MDT decision and the treatment provided was detailed. Management practices were discussed according to the guideline\u2019s recommendations. Overall survival (using the Kaplan\u2013Meier method) and net survival (using the Pohar-Perme estimator) were calculated. Among 538 incident BC cases, 147 (27.3%) were MIBCs. Diagnostic practices displayed a relevant locoregional assessment of BC. Almost all cases (n\u2009=\u2009136, 92.5%) were assessed during an uro-oncological MDT with a median time from diagnosis of 18\u2009days (first quartile:12-third quartile:32). Discrepancies appeared between MDT decisions and treatments delivered: 71 out of 86 subjects received the recommended cystectomy or chemoradiation (with or without neoadjuvant chemotherapy); 6 out of 11 had the recommended radio- or chemotherapy; and 9 patients did not undergo any specific treatment despite the MDT decision. Cystectomy was the most common treatment performed; the time to surgery appeared consistent with the guideline\u2019s recommendations. Forty people only received supportive care. Still, the 5-year overall and net survival was poor, with 19% (13\u201326) and 22% (14\u201331), respectively. The 5-year net survival was 35% (23\u201348) for people who underwent curative-intent treatments. MIBC management remains challenging even for cases assessed during an MDT. Many people did not undergo any specific treatment. Prognosis was poor even when curative-intent therapies were delivered. Efforts to reduce exposure to risk factors such as tobacco smoking and occupational exposures must be maintained.<\/jats:p>","DOI":"10.1093\/intqhc\/mzae040","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T11:56:04Z","timestamp":1715255764000},"source":"Crossref","is-referenced-by-count":0,"title":["Practice patterns and survival outcomes for muscle-invasive bladder cancer: real-life experience in a general population setting"],"prefix":"10.1093","volume":"36","author":[{"given":"Sandrine D","family":"Plouvier","sequence":"first","affiliation":[{"name":"General Cancer Registry of Lille area, C2RC , Bld du Pr Jules Leclercq, Lille 59037, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautier","family":"Marcq","sequence":"additional","affiliation":[{"name":"Urology Department, Claude Huriez Hospital, CHU Lille , Rue Michel Polonowski, Lille F-59000, France"},{"name":"University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, UMR9020-U1277\u2014CANTHER\u2014Cancer Heterogeneity Plasticity and Resistance to Therapies , Lille F-59000, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Vankemmel","sequence":"additional","affiliation":[{"name":"Cabinet urologie, H\u00f4pital priv\u00e9 Le Bois , 85 av Marx Dormoy, Lille 59000, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Colin","sequence":"additional","affiliation":[{"name":"Service d\u2019Urologie, H\u00f4pital priv\u00e9 La Louvi\u00e8re , rue des Vicaires, Lille 59000, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Bonnal","sequence":"additional","affiliation":[{"name":"Service d\u2019Urologie, Groupement des h\u00f4pitaux de l\u2019Institut Catholique de Lille, Universit\u00e9 nord de France , Rue du Grand But, 59160"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Leroy","sequence":"additional","affiliation":[{"name":"Department of Pathology, CHU Lille, Universit\u00e9 de Lille , Bld du Pr Jules Leclercq, Lille 59037, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien","family":"Saint","sequence":"additional","affiliation":[{"name":"Service d\u2019Urologie Transplantation CHU Amiens Picardie, Laboratoire EPROAD EA 4669 UPJV , 1 Rond-Point du Professeur Christian Cabrol, Amiens cedex 01 80054, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Pasquier","sequence":"additional","affiliation":[{"name":"Academic Department of Radiation Oncology, Centre Oscar Lambret , 3 rue Combemale, CEDEX Lille F-59020, France"},{"name":"University Lille & CNRS, Centrale Lille, UMR 9189\u2014CRIStAL , Lille F-59000, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,5,6]]},"reference":[{"key":"2024052117133119100_R1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"2024052117133119100_R2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur Urol"},{"key":"2024052117133119100_R3","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08261-1","article-title":"Cancer incidence and mortality trends in France over 1990-2018 for solid tumors: the sex gap is narrowing","volume":"21","author":"Defossez","year":"2021","journal-title":"BMC Cancer"},{"key":"2024052117133119100_R4","article-title":"Survie des personnes atteintes de cancer en France m\u00e9tropolitaine 1989-2018 \u2013 Vessie","volume-title":"Boulogne-Billancourt: Institut national du cancer","author":"Daubisse-Marliac","year":"2021"},{"key":"2024052117133119100_R5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.respe.2011.10.006","article-title":"Elements of completeness and results of the first year of registration of the \u201cRegistre g\u00e9n\u00e9ral des cancers de Lille et de sa r\u00e9gion\u201d","volume":"6","author":"Ligier","year":"2012","journal-title":"Rev Epidemiol Sante Publique"},{"key":"2024052117133119100_R6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/21681805.2015.1085089","article-title":"Swedish national registry of urinary bladder cancer: no difference in relative survival over time despite more aggressive treatment","volume":"50","author":"Jahnson","year":"2016","journal-title":"Scand J Urol"},{"key":"2024052117133119100_R7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/0284186X.2020.1723164","article-title":"Impact of age on bladder cancer management practices: a general population study","volume":"5","author":"Plouvier","year":"2020","journal-title":"Acta Oncol"},{"key":"2024052117133119100_R8","article-title":"Urological tumours. Urinary bladder","volume-title":"TNM Classification of Malignant Tumours","author":"Sobin","year":"2009","edition":"7th edn."},{"key":"2024052117133119100_R9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2024052117133119100_R10","article-title":"Histopathological typing of urinary bladder tumours","volume-title":"International histological classification of tumours No 19","author":"Mostofi","year":"1973"},{"key":"2024052117133119100_R11","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology Consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"article-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs","year":"2004","author":"Eble","key":"2024052117133119100_R12"},{"key":"2024052117133119100_R13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","article-title":"On estimation in relative survival","volume":"68","author":"Pohar Perme","year":"2012","journal-title":"Biometrics"},{"key":"2024052117133119100_R14","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0090-4295(00)00523-9","article-title":"Gender differences in stage-adjusted bladder cancer survival","volume":"55","author":"Mungan","year":"2000","journal-title":"Urology"},{"key":"2024052117133119100_R15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016606","article-title":"Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe)","volume":"7","author":"H\u00e4ggstr\u00f6m","year":"2017","journal-title":"BMJ Open"},{"key":"2024052117133119100_R16","doi-asserted-by":"publisher","first-page":"S255","DOI":"10.1016\/S1166-7087(10)70043-9","article-title":"Recommendations Onco-Urology 2010: Urothelial tumors","volume":"20","author":"Pfister","year":"2010","journal-title":"Prog Urol"},{"article-title":"Guidelines on bladder cancer. Muscle-invasive and metastatic bladder cancer: update April 2010","year":"2010","author":"Stenzl","key":"2024052117133119100_R17"},{"key":"2024052117133119100_R18","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/S1166-7087(20)30751-X","article-title":"French ccAFU guidelines \u2013 update 2020-2022: bladder cancer","volume":"30","author":"Roupr\u00eat","year":"2020","journal-title":"Prog Urol"},{"key":"2024052117133119100_R19","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-14-377","article-title":"Strategies to improve the efficiency and utility of multidisciplinary team meetings in urology cancer care: a survey study","volume":"14","author":"Lamb","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"2024052117133119100_R20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/bju.15856","article-title":"The influence of multidisciplinary team meetings on treatment decisions in advanced bladder cancer","volume":"131","author":"Walraven","year":"2023","journal-title":"BJU Int"},{"year":"2013","author":"Plans cancers de 2003 \u00e0","key":"2024052117133119100_R21"},{"key":"2024052117133119100_R22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bju.12742","article-title":"Predictors of preoperative delays before radical cystectomy for bladder cancer in Quebec, Canada: a population-based study","volume":"115","author":"Santos","year":"2015","journal-title":"BJU Int"},{"key":"2024052117133119100_R23","doi-asserted-by":"crossref","first-page":"166.e1","DOI":"10.1016\/j.urolonc.2015.11.006","article-title":"The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis","volume":"34","author":"Bruins","year":"2016","journal-title":"Oncol Urol"},{"key":"2024052117133119100_R24","first-page":"9","article-title":"Timing of radical cystectomy in Central Europe \u2013 multicenter study on factors influencing the time from diagnosis to radical treatment of bladder cancer patients","volume":"68","author":"Poletajew","year":"2015","journal-title":"Cent European J Urol"},{"key":"2024052117133119100_R25","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ijc.28716","article-title":"Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer","volume":"135","author":"Goossens-Laan","year":"2014","journal-title":"Int J Cancer"}],"container-title":["International Journal for Quality in Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/intqhc\/advance-article-pdf\/doi\/10.1093\/intqhc\/mzae040\/57465275\/mzae040.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/intqhc\/article-pdf\/36\/2\/mzae040\/57800922\/mzae040.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/intqhc\/article-pdf\/36\/2\/mzae040\/57800922\/mzae040.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T17:13:47Z","timestamp":1716311627000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/intqhc\/article\/doi\/10.1093\/intqhc\/mzae040\/7667589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5,18]]}},"URL":"https:\/\/doi.org\/10.1093\/intqhc\/mzae040","relation":{},"ISSN":["1353-4505","1464-3677"],"issn-type":[{"type":"print","value":"1353-4505"},{"type":"electronic","value":"1464-3677"}],"subject":[],"published-other":{"date-parts":[[2024,4,1]]},"published":{"date-parts":[[2024,4,1]]},"article-number":"mzae040"}}